Biomarkers of Helicobacter pylori-associated gastric cancer

20Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Helicobacter pylori-associated gastric cancer is a major cause of morbidity and mortality worldwide, and is predicted to become even more common in developing countries as the population ages. Since gastric cancer develops slowly over years to decades, and typically progresses though a series of well-defined histologic stages, cancer biomarkers have potential to identify asymptomatic individuals in whom surgery might be curative, or even those for whom antibiotics to eradicate H. pylori could prevent neoplastic transformation. Here we describe some of the challenges of biomarker discovery, summarize current approaches to biomarkers of gastric cancer, and explore some recent novel strategies. © 2013 Landes Bioscience.

Cite

CITATION STYLE

APA

Cooke, C. L., Torres, J., & Solnick, J. V. (2013, July 12). Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. https://doi.org/10.4161/gmic.25720

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free